Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

DK-AH 268 MeSH Supplementary Concept Data 2025


MeSH Supplementary
DK-AH 268
Unique ID
C087873
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C087873
Entry Term(s)
1,3,4,5-tetrahydro-7,8-dimethoxy-3-((1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl)methyl)-2H-3-benzazepin-2-one hydrochloride
DK-AH 269
DK-AH-268
DK-AH-269
Registry Numbers
155233-34-4
CAS Type 1 Name
2H-3-Benzazepin-2-one, 3-((1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl)methyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride, (R)-
Heading Mapped to
*Benzazepines
Frequency
15
Note
a bradycardic agent and sinus node inhibitor
Source
Neuroscience 1994 Mar;59(2):363-73
Date of Entry
1994/07/19
Revision Date
2002/05/01
DK-AH 268 Preferred
1,3,4,5-tetrahydro-7,8-dimethoxy-3-((1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl)methyl)-2H-3-benzazepin-2-one hydrochloride Broader
DK-AH 269 Related
page delivered in 0.004s